More than Ankylosing Spondylitis
Costa, T.; Falcão, S.; Mateus, M.; Branco, J.
Acta Reumatologica Portuguesa 2018
2018
ISSN/ISBN: 2184-8777 PMID: 29397394 Document Number: 697707
Document emailed within 1 workday
Related Documents
Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Menkes, C.J.; Kahan, A.; Feldmann, J.L.; Vinh, T. 1983: Destructive cervical spondylitis. An unusual initial manifestation of ankylosing spondylitis Presse Medicale 12(4): 227-229
Saraux, A. 2011: Ankylosing spondylitis La Revue du Praticien 61(7): 999-1006
Jajić, Z. 2000: Ankylosing spondylitis Reumatizam 47(2): 18-19
Russell, A.S. 1979: The prevalence of ankylosing spondylitis Journal of Rheumatology 6(6): 603-605
Miceli-Richard, C.; Dougados, M. 2002: NSAIDs in ankylosing spondylitis Clinical and Experimental Rheumatology 20(6 Suppl 28: S65-S66
Huang, F.; Wei, J.C.C.; Breban, M. 2002: Thalidomide in ankylosing spondylitis Clinical and Experimental Rheumatology 20(6 Suppl 28: S158-S161
Calin, A.; Edmunds, L.; Kennedy, L.G. 1993: Fatigue in ankylosing spondylitis--why is it ignored? Journal of Rheumatology 20(6): 991-995
Fassbender, H.G. 1975: Pathology of ankylosing spondylitis Die Medizinische Welt 26(45): 2039
Elyan, M.; Khan, M.Asim. 2006: Diagnosing ankylosing spondylitis Journal of Rheumatology. Supplement 78: 12-23
Van der Linden, S.M.; Cats, A.; Valkenburg, H.A. 1988: On the prevalence of ankylosing spondylitis Journal of Rheumatology 15(2): 375-377
Clegg, D.O. 2006: Treatment of ankylosing spondylitis Journal of Rheumatology. Suppl 78: 24-31
Gran, J.T.; Husby, G. 1987: On the prevalence of ankylosing spondylitis Journal of Rheumatology 14(1): 174-175
Mitsui, H.; Sonozaki, H. 1981: Ankylosing spondylitis in Japan Ryumachi 21 Suppl: 45-49
Russell, A.S. 1988: Klebsiella and ankylosing spondylitis Clinical and Experimental Rheumatology 6(1): 1-2